rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
2001-9-13
|
pubmed:abstractText |
The aim of the study was to investigate if a short-term administration of high-dose Tamoxifen (Tam) could affect the expression of biologically relevant biochemical parameters in cervical cancer tissue.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1078-0432
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2656-61
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11555576-Adult,
pubmed-meshheading:11555576-Aged,
pubmed-meshheading:11555576-Antigens, CD31,
pubmed-meshheading:11555576-Antineoplastic Agents, Hormonal,
pubmed-meshheading:11555576-Apoptosis,
pubmed-meshheading:11555576-Blood Vessels,
pubmed-meshheading:11555576-Carcinoma, Squamous Cell,
pubmed-meshheading:11555576-Dose-Response Relationship, Drug,
pubmed-meshheading:11555576-Female,
pubmed-meshheading:11555576-Humans,
pubmed-meshheading:11555576-Immunohistochemistry,
pubmed-meshheading:11555576-Keratins,
pubmed-meshheading:11555576-Ki-67 Antigen,
pubmed-meshheading:11555576-Middle Aged,
pubmed-meshheading:11555576-Receptors, Estrogen,
pubmed-meshheading:11555576-Tamoxifen,
pubmed-meshheading:11555576-Uterine Cervical Neoplasms
|
pubmed:year |
2001
|
pubmed:articleTitle |
Tamoxifen modulates the expression of Ki67, apoptosis, and microvessel density in cervical cancer.
|
pubmed:affiliation |
Department of Gynecology/Obstetrics, Catholic University of Rome, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|